Atrás
44
Rango del Día
$17.65
$18.60
Rango de 52 Semanas
$16.76
$28.75
Volumen
2,116,522
Promedio 50D / 200D
$21.58
/
$22.49
Cierre Anterior
$18.13
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 25.2 | 0.4 |
| P/B | 2.9 | 2.9 |
| ROE % | 12.5 | 3.8 |
| Net Margin % | 4.5 | 3.9 |
| Rev Growth 5Y % | 26.7 | 10.0 |
| D/E | 0.1 | 0.2 |
Puntos Clave
Revenue grew 26.67% annually over 5 years — strong growth
ROE of 12.48% — decent returns on equity
Debt/Equity of 0.05 — conservative balance sheet
Generating 191.78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 16.27%
Cash machine — converts 327.72% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
26.67%
Revenue (1Y)10.40%
Earnings (1Y)7.70%
FCF Growth (3Y)1.77%
Calidad
Return on Equity
12.48%
ROIC11.84%
Net Margin4.54%
Op. Margin6.62%
Seguridad
Debt / Equity
0.05
Current Ratio2.73
Interest Coverage0.00
Valoración
P/E Ratio
25.21
P/B Ratio2.86
EV/EBITDA16.26
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.40% | Revenue Growth (3Y) | 8.80% |
| Earnings Growth (1Y) | 7.70% | Earnings Growth (3Y) | -2.88% |
| Revenue Growth (5Y) | 26.67% | Earnings Growth (5Y) | -2.88% |
| Profitability | |||
| Revenue (TTM) | 1.29B | Net Income (TTM) | 58.52M |
| ROE | 12.48% | ROA | 7.88% |
| Gross Margin | 23.63% | Operating Margin | 6.62% |
| Net Margin | 4.54% | Free Cash Flow (TTM) | 191.78M |
| ROIC | 11.84% | FCF Growth (3Y) | 1.77% |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 2.73 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 25.21 | P/B Ratio | 2.86 |
| P/S Ratio | 1.14 | PEG Ratio | 2.45 |
| EV/EBITDA | 16.26 | Dividend Yield | 0.00% |
| Market Cap | 1.48B | Enterprise Value | 1.39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.29B | 1.17B | 1.09B | 786.91M | 500.62M |
| Net Income | 58.52M | 54.34M | 62.04M | 30.36M | 65.77M |
| EPS (Diluted) | 0.65 | 0.57 | 0.62 | 0.30 | 0.66 |
| Gross Profit | 304.48M | 253.36M | 238.80M | 167.33M | 112.14M |
| Operating Income | 85.28M | 67.46M | 62.18M | 23.34M | 32.34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 742.44M | 607.10M | 756.62M | 542.99M | 358.07M |
| Total Liabilities | 226.39M | 185.04M | 203.19M | 166.02M | 106.24M |
| Shareholders' Equity | 516.04M | 422.06M | 553.43M | 376.97M | 251.82M |
| Total Debt | 24.00M | 19.27M | 19.39M | 7.71M | 8.65M |
| Cash & Equivalents | 112.24M | 162.31M | 97.30M | 120.08M | 91.41M |
| Current Assets | 551.78M | 472.72M | 640.41M | 433.86M | 258.54M |
| Current Liabilities | 202.39M | 168.63M | 185.95M | 159.54M | 98.82M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#529 of 1024
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026